Adrian G. Sacher

9.0k citations

153 papers · 3.1k indexed · 1 hit paper · h-index 29

Cancer Research top 2%
- Cancer Genomics and Diagnostics 43
Oncology top 1%
- Lung Cancer Research Studies 33
- Cancer Immunotherapy and Biomarkers 29
- Colorectal Cancer Treatments and Studies 20
- CAR-T cell therapy research 11
- Peptidase Inhibition and Analysis 7
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations 78
- Lung Cancer Diagnosis and Treatment 20
Genetics top 5%
Pathology and Forensic Medicine top 5%

Co-authors: Geoffrey R. Oxnard Leena Gandhi Pasi A. Jänne Stacy L. Mach Suzanne E. Dahlberg Natasha B. Leighl Ryan S. Alden Cloud P. Paweletz
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (38 papers)
Partner nations: Canada United States Australia

In The Last Decade

Adrian G. Sacher

136 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Adrian G. Sacher

Since Specialization

Citations

This map shows the geographic impact of Adrian G. Sacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian G. Sacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian G. Sacher more than expected).

Fields of papers citing papers by Adrian G. Sacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian G. Sacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian G. Sacher. The network helps show where Adrian G. Sacher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adrian G. Sacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adrian G. Sacher Line = papers co-authored together Adrian G. Sacher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms British Journal of Cancer ·Joshua C. Rosen,Pinjiang Cao,Nhu‐An Pham,Matthew Waas,Quan Li,Katrina Hueniken,Mutian Wang,Roya Navab,Leanne Wybenga-Groot,Nikolina Radulovich,Michael Niedbala,Alex Koers,Sarah J. Ross,Michael F. Moran,Adrian G. Sacher,Ming‐Sound Tsao	2025	0
2	The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer Therapeutic Advances in Medical Oncology ·Barbara Melosky,Rosalyn A. Juergens,Shantanu Banerji,Adrian G. Sacher,Paul Wheatley‐Price,Stephanie Snow,Ming‐Sound Tsao,Natasha B. Leighl,Ilidio Martins,Parneet Cheema,Geoffrey Liu,Quincy S. Chu	2025	0
3	Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research JTO Clinical and Research Reports ·Cheol‐Kyu Park,Maryam Khalil,Nhu‐An Pham,Stephanie M. Wong,Dalam Ly,Adrian G. Sacher,Ming‐Sound Tsao	2024	2
4	Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors JTO Clinical and Research Reports ·Abdulrahman Alghabban,Lucy Corke,Hans Katzberg,Vera Bril,Carolina Barnett‐Tapia,Warren Mason,Raed Alothman,Aideen E. Ryan,David W. Hogg,Srikala S. Sridhar,Neesha C. Dhani,Anna Spreafico,Lawson Eng,Adrian G. Sacher,Penelope A. Bradbury,Geoffrey Liu,Natasha B. Leighl,Frances A. Shepherd	2024	0
5	Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors Clinical Cancer Research ·Yoonha Choi,Neekesh V. Dharia,Tomi Jun,Julie Chang,Stephanie Royer‐Joo,Kenneth K. Yau,Zoe J. Assaf,Junko Aimi,Smruthy Sivakumar,Meagan Montesion,Adrian G. Sacher,Patricia LoRusso,Jayesh Desai,Jennifer L. Schutzman,Zhen Shi,(unknown)	2024	9
6	Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study BMJ Open ·Soumaya Labidi,Nicholas Meti,Reeta Barua,Mengqi Li,Jamila Riromar,Di Jiang,Nazanin Fallah‐Rad,Srikala S. Sridhar,Sonia V. del Rincón,Rossanna C. Pezo,Cristiano Ferrario,Susanna Y. Cheng,Adrian G. Sacher,April A. N. Rose	2024	2
7	Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Ferdinandos Skoulidis,Kristof Cuppens,Adrian G. Sacher,Vamsidhar Velcheti,Dae Ho Lee,Mark T. Lin,Tharu M. Fernando,Shuai Li,Denise Bradley,Martina Zarak Crnkovic,Michael S. Mathisen	2024	6
8	Circulating metabolic profiling as a biomarker for immune checkpoint blockade efficacy. Journal of Clinical Oncology ·Erick Figueiredo Saldanha,Sally C. M. Lau,Robert C. Laister,Ben X. Wang,Susanne Penny,Devanand M. Pinto,Adrian G. Sacher,Samuel D. Saibil	2024	1
9	ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results Nature Medicine ·Valsamo Anagnostou,Cheryl Ho,Garth Nicholas,Rosalyn A. Juergens,Adrian G. Sacher,Andrea S. Fung,Paul Wheatley‐Price,Scott A. Laurie,Benjamin Levy,Julie R. Brahmer,Archana Balan,Noushin Niknafs,Egor Avrutin,Liting Zhu,Mark Sausen,Penelope A. Bradbury,Jill O’Donnell-Tormey,Pierre Olivier Gaudreau,Keyue Ding,Janet Dancey	2023	66
10	Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC Current Oncology ·Parneet Cheema,Shantanu Banerji,Normand Blais,Quincy S. Chu,Rosalyn A. Juergens,Natasha B. Leighl,Adrian G. Sacher,Brandon S. Sheffield,Stephanie Snow,Mark Vincent,Paul F. Wheatley‐Price,Stephen Yip,Barbara Melosky	2023	1
11	A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer Clinical Lung Cancer ·Wade T. Iams,Meridith L. Balbach,Sharon Phillips,Adrian G. Sacher,Christine M. Bestvina,Vamsidhar Velcheti,Xiao Wang,Melina E. Marmarelis,Nan Sethakorn,Ticiana Leal,Paul Sackstein,Chul Kim,Md Andrew Robinson,Kathan Mehta,Robert Hsu,Jorge J. Nieva,Tejas Patil,D. Ross Camidge	2023	2
12	The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer Therapeutic Advances in Medical Oncology ·Barbara Melosky,Parneet Cheema,Rosalyn A. Juergens,Natasha B. Leighl,Geoffrey Liu,Paul Wheatley‐Price,Adrian G. Sacher,Stephanie Snow,Ming‐Sound Tsao,Deanna McLeod,Quincy S. Chu	2021	4
13	The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer Lung Cancer ·Barbara Melosky,Paul Wheatley‐Price,Rosalyn A. Juergens,Adrian G. Sacher,Natasha B. Leighl,Ming‐Sound Tsao,Parneet Cheema,Stephanie Snow,Geoffrey Liu,Paul Card,Quincy S. Chu	2021	51
14	MA14.03 Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib Journal of Thoracic Oncology ·Ferdinandos Skoulidis,Martin Schüler,Jennifer Moriatis Wolf,Fabrice Barlési,Timothy Price,Grace K. Dy,Ramaswamy Govindan,Hossein Borghaei,Gerald S. Falchook,B. Li,Suresh S. Ramalingam,Adrian G. Sacher,Alexander I. Spira,Toshiaki Takahashi,Abraham Anderson,Agnes Ang,Tian Dai,Donna Flesher,Paul Cifuentes,V. Velcheti	2021	1
15	Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors Clinical Lung Cancer ·Sally C. M. Lau,Aline Fusco Fares,Lisa W. Le,Kate M. Mackay,Spencer Soberano,Sze Wah Samuel Chan,Elliot Smith,Malcolm Ryan,Ming‐Sound Tsao,Penelope A. Bradbury,Prodipto Pal,Frances A. Shepherd,Geoffrey Liu,Natasha B. Leighl,Adrian G. Sacher	2021	54
16	The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance Lung Cancer ·Grainne M. O’Kane,Geoffrey Liu,Tracy Stockley,Muqdas Shabir,Tong Zhang,Jennifer Law,Lisa W. Le,Adrian G. Sacher,Frances A. Shepherd,Penelope A. Bradbury,Natasha B. Leighl	2019	14
17	P2.03-03 Upfront Next Generation Sequencing in NSCLC: A Publicly Funded Perspective Journal of Thoracic Oncology ·Kirstin Perdrizet,Tracy Stockley,Ming‐Sound Tsao,Joshua C. Morganstein,Suzanne Kamel‐Reid,Laura Ranich,F. Shepherd,Penelope A. Bradbury,G. Liu,D. Hwang,Prodipto Pal,Joerg Schwock,Scott Boerner,Adrian G. Sacher,J. Law,N. B. Leighl	2018	0
18	Acquired MET D1228V Mutation and Resistance to MET Inhibition in Lung Cancer Cancer Discovery ·Magda Bahcall,Taebo Sim,Cloud P. Paweletz,Jyoti D. Patel,Ryan S. Alden,Yanan Kuang,Adrian G. Sacher,Nam Doo Kim,Christine Lydon,Mark M. Awad,Michael T. Jaklitsch,Lynette M. Sholl,Pasi A. Jänne,Geoffrey R. Oxnard	2016	114
19	Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients Clinical Cancer Research ·Cloud P. Paweletz,Adrian G. Sacher,Chris K. Raymond,Ryan S. Alden,Allison O’Connell,Stacy L. Mach,Yanan Kuang,Leena Gandhi,Paul T. Kirschmeier,Jessie M. English,Lee P. Lim,Pasi A. Jänne,Geoffrey R. Oxnard	2015	177
20	Shifting Patterns in the Interpretation of Phase III Clinical Trial Outcomes in Advanced Non–Small-Cell Lung Cancer: The Bar Is Dropping Journal of Clinical Oncology ·Adrian G. Sacher,Lisa W. Le,Natasha B. Leighl	2014	33

About Adrian G. Sacher

Adrian G. Sacher is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 153 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (78 papers), Cancer Genomics and Diagnostics (43 papers), Lung Cancer Research Studies (33 papers), Cancer Immunotherapy and Biomarkers (29 papers), Lung Cancer Diagnosis and Treatment (20 papers), Colorectal Cancer Treatments and Studies (20 papers), CAR-T cell therapy research (11 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.7k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Adrian G. Sacher has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Geoffrey R. Oxnard, Leena Gandhi, Pasi A. Jänne, Stacy L. Mach, Suzanne E. Dahlberg, Natasha B. Leighl, Ryan S. Alden, Cloud P. Paweletz, Allison O’Connell and Lisa W. Le. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact